Kiniksa Pharmaceuticals International, plc

Nasdaq:KNSA

Pharmaceutical Preparations·LONDON

Governanceproxy statements · beneficial ownership

Proxy Statements

21 shown

Filed	Form	Description
5/28/25	DEFA14A	DEFA14A	→
5/9/25	DEFA14A	DEFA14A	→
4/21/25	DEFA14A	DEFA14A	→
4/21/25	DEF 14A	DEF 14A	→
4/10/25	PRE 14A	PRE 14A	→
5/29/24	DEFA14A	DEFA14A	→
↓

Ownership Filings

40 shown

Filed	Form	Description
3/11/26	4	4	→
3/4/26	4	4	→
2/12/26	4	4	→
2/11/26	4	4	→
2/4/26	4	4	→
2/4/26	4	4	→
↓